{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:31:23Z","timestamp":1780079483706,"version":"3.54.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0100634","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T20:24:26Z","timestamp":1403900666000},"page":"e100634","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Masatake","family":"Kurita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,27]]},"reference":[{"key":"ref1","first-page":"42","article-title":"Global mental health","volume":"54","author":"MC Kastrup","year":"2007","journal-title":"Dan Med Bull"},{"key":"ref2","first-page":"4","article-title":"Toward an understanding of bipolar disorder and its origin","volume":"64 Suppl 6","author":"AJ Rush","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000151520","article-title":"Functional impairment in patients with remitted bipolar disorder","volume":"77","author":"AR Rosa","year":"2008","journal-title":"Psychother Psychosom"},{"key":"ref4","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-5618.2005.00212.x","article-title":"Atypical antipsychotics: newer options for mania and maintenance therapy","volume":"7 Suppl 4","author":"E Vieta","year":"2005","journal-title":"Bipolar Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"LN Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.1990.tb06442.x","article-title":"Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables","volume":"81","author":"JM Azorin","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hup.804","article-title":"Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders","volume":"21","author":"R Yoshimura","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"M Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004850-199300820-00007","article-title":"Depot antipsychotics in bipolar affective disorder","volume":"8","author":"E White","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-2007-1019628","article-title":"Course of the manic-depressive cycle and changes caused by treatment","volume":"13","author":"A Kukopulos","year":"1980","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"BS Fernandes","year":"2011","journal-title":"J Psychiatr Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","article-title":"A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder","volume":"162","author":"JR Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"SA Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"RC Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1399-5618.2008.00459.x","article-title":"Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders","volume":"10","author":"P Monteleone","year":"2008","journal-title":"Bipolar Disord"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"NC Andreasen","year":"2010","journal-title":"Biol Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/js950361q","article-title":"Determination of 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in human plasma by a simple and rapid high-performance liquid chromatography assay","volume":"85","author":"PK Yeung","year":"1996","journal-title":"J Pharm Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hup.685","article-title":"An open study of risperidone liquid in the acute phase of schizophrenia","volume":"20","author":"R Yoshimura","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e39212","DOI":"10.1371\/journal.pone.0039212","article-title":"Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study","volume":"7","author":"M Kurita","year":"2012","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"A Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref22","first-page":"CD004052","article-title":"Valproate for acute mood episodes in bipolar disorder","author":"K Macritchie","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"F Kapczinski","year":"2011","journal-title":"J Psychiatr Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0006-3223(89)90245-X","article-title":"Plasma catecholamine metabolites and treatment response at neuroleptic steady state","volume":"25","author":"MB Bowers Jr","year":"1989","journal-title":"Biol Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/0006-2952(68)90119-6","article-title":"3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid","volume":"17","author":"SM Schanberg","year":"1968","journal-title":"Biochem Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2004.03.006","article-title":"24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression","volume":"38","author":"HW Koenigsberg","year":"2004","journal-title":"J Psychiatr Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1176\/ajp.146.11.1427","article-title":"Apparent phase advance in diurnal MHPG rhythm in depression","volume":"146","author":"HE Gwirtsman","year":"1989","journal-title":"Am J Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.psychres.2010.07.028","article-title":"Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects","volume":"186","author":"SW Choi","year":"2011","journal-title":"Psychiatry Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/07420520802387773","article-title":"Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences","volume":"25","author":"A Piccinni","year":"2008","journal-title":"Chronobiol Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.mp.4001009","article-title":"Significant dissociation of brain and plasma kinetics with antipsychotics","volume":"7","author":"J Tauscher","year":"2002","journal-title":"Mol Psychiatry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0100634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T17:05:07Z","timestamp":1689354307000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0100634"}},"subtitle":[],"editor":[{"given":"Chunyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,27]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0100634","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,27]]}}}